Intellectual Property India Publishes Patent Application for 'Crystalline Form Of An N-Heteroarylsulphonamide, Compositions And Methods Thereof' Filed by Pacylex Pharmaceuticals Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065417 A) filed by Pacylex Pharmaceuticals Inc., Calgary, Canada, on July 9, for 'crystalline form of an n-heteroarylsulphonamide, compositions and methods thereof.'

Inventor(s) include Scott, Ian Leslie; Smith, Garry Robert; Suleiman, Osama; Green, Emma Jane; and Roberge, Jacques Yves.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "A crystalline form of N-heteroarylsulphonamide 2,6-dichloro-N-(3-isobutyl-1,5- dimethyl-1H-pyrazol-4-yl)-4-(2-(piperazin-1-yl)pyridin-4-yl)benzenesulfonamide and pharmaceutical compositions thereof; and methods of preparing said crystalline form, and methods of using said crystalline form in the treatment of disease."

The patent application was internationally filed on Dec. 28, 2023, under International application No.PCT/CA2023/051770.

Disclaimer: Curated by HT Syndication.